Jacob Bor, SD
Assistant Professor
Boston University School of Public Health
Dept of Global Health

SD, Harvard School of Public Health

Jacob Bor, ScD, SM, is Assistant Professor and Peter T. Paul Career Development Professor in the Department of Global Health. His research applies the analytical tools of economics to the study of population health, with a focus on HIV treatment and prevention in southern Africa. Current research interests include economic spillover effects of HIV treatment on patients, households, and communities; decision-making in HIV-endemic risk environments; population health impacts of social policy; and causal inference in public health research. His work has been published in Science, Lancet Global Health, Epidemiology, and Health Affairs. Prior to his graduate training at Harvard School of Public Health, Dr. Bor worked with an HIV-prevention NGO in Botswana, Lesotho, and South Africa. He is an affiliate of the Africa Centre for Population Health (www.africacentre.ac.za) and Health Economics and Epidemiology Research Office (www.heroza.org), both in South Africa, and BUSPH's Center for Global Health and Development. For additional and up-to-date information: http://sites.bu.edu/jbor.

Center Faculty Member
Boston University School of Public Health
Center for Global Health & Development

Economic, Health & Behavoral Dimensions of HIV Treatment Scale-UP
03/20/2015 - 01/31/2018 (PI)
NIH/National Institute of Mental Health

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Bor J, Ahmed S, Fox MP, Rosen S, Meyer-Rath G, Katz IT, Tanser F, Pillay D, Bärnighausen T. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study. PLoS One. 2017; 12(6):e0178249.View Related Profiles. PMID: 28617805.
  2. Bärnighausen T, Tugwell P, Røttingen JA, Shemilt I, Rockers P, Geldsetzer P, Lavis J, Grimshaw J, Daniels K, Brown A, Bor J, Tanner J, Rashidian A, Barreto M, Vollmer S, Atun R. Quasi-experimental study designs series - Paper 4: uses and value. J Clin Epidemiol. 2017 Mar 29.View Related Profiles. PMID: 28365303; DOI: 10.1016/j.jclinepi.2017.03.012;.
  3. Bärnighausen T, Oldenburg C, Tugwell P, Bommer C, Cara Ebert, Barreto M, Djimeu E, Haber N, Waddington H, Rockers P, Sianesi B, Bor J, Fink G, Valentine J, Tanner J, Stanley T, Sierra E, Tchetgen ET, Atun R, Vollmer S. Quasi-experimental study designs series - Paper 7: assessing the assumptions. J Clin Epidemiol. 2017 Mar 29.View Related Profiles. PMID: 28365306; DOI: 10.1016/j.jclinepi.2017.02.017;.
  4. Maskew M, Bor J, Hendrickson C, MacLeod W, Bärnighausen T, Pillay D, Sanne I, Carmona S, Stevens W, Fox MP. Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study. BMC Health Serv Res. 2017 Jan 17; 17(1):41.View Related Profiles. PMID: 28095905; DOI: 10.1186/s12913-016-1940-2;.
  5. Brennan AT, Davies MA, Bor J, Wandeler G, Stinson K, Wood R, Prozesky H, Tanser F, Fatti G, Boulle A, Sikazwe I, Wool-Kaloustian K, Yuannoutsos C, Leroy V, de Rekeneire N, Fox MP. Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa? AIDS. 2017 Jan 02; 31(1):147-157.View Related Profiles. PMID: 27776039.
  6. Brennan AT, Bor J, Davies MA, Conradie F, Maskew M, Long L, Sanne I, Fox MP. Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa. Trop Med Int Health. 2017 Feb; 22(2):241-251.View Related Profiles. PMID: 27862762; DOI: 10.1111/tmi.12811;.
  7. Reniers G, Blom S, Calvert C, Martin-Onraet A, Herbst AJ, Eaton JW, Bor J, Slaymaker E, Li ZR, Clark SJ, Bärnighausen T, Zaba B, Hosegood V. Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort study. Lancet HIV. 2017 Mar; 4(3):e113-e121. PMID: 27956187; DOI: 10.1016/S2352-3018(16)30225-9;.
  8. Bor J. Commentary: Can''t WaSH Without Water: Instrumental Variables Evidence from a Randomized Trial. Epidemiology. 2016 Sep; 27(5):761-4. PMID: 27276026; DOI: 10.1097/EDE.0000000000000523;.
  9. Bor J. Capitalizing on Natural Experiments to Improve Our Understanding of Population Health. Am J Public Health. 2016 Aug; 106(8):1388-9. PMID: 27400352; DOI: 10.2105/AJPH.2016.303294;.
  10. Dickman SL, Woolhandler S, Bor J, McCormick D, Bor DH, Himmelstein DU. Health Spending For Low-, Middle-, And High-Income Americans, 1963-2012. Health Aff (Millwood). 2016 Jul 01; 35(7):1189-96. PMID: 27385233; DOI: 10.1377/hlthaff.2015.1024;.
Showing 10 of 33 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 31 publications over 8 distinct years, with a maximum of 9 publications in 2015

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Population health, economics, causal inference, HIV/AIDS
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Bor's Networks
Click the "See All" links for more information and interactive visualizations
Similar People